By Le Parisien with AFP
The December 10, 2019 at 9:22 p.m.
The National Assembly voted on Tuesday for manufacturers to affix a pictogram “not recommended for pregnant women” if their products contain endocrine disruptors posing risks to the development of the baby.
The two ads collide. The government is launching its second national strategy on endocrine disruptors (SNPE 2), at a time when Public Health France (SPF) publishes the results of the Esteban study on the pollutant impregnation of the French population.
The executive thus intends to show its voluntarism while the results of this study, described as “a real turning point in public policies ” by Agnès Buzyn, are proving alarming.
ECHA’s endocrine disruptor (ED) assessment list includes the substances undergoing an ED assessment under REACH or the Biocidal Products Regulation that have been brought for discussion to ECHA’s ED Expert Group.
The aim of this website is to primarily inform stakeholders about the current status of substances identified as endocrine disruptors (EDs), or under evaluation for endocrine disrupting properties within the EU.
The intention of compiling this information is to improve knowledge about EDs, increase transparency, coherence and consistency, as well as coordination across legislative areas. It is also possible that identification and regulation of additional EDs may be facilitated by this single repository of information.
ECHA/NR/18/36
Scientific criteria have been agreed to identify endocrine disruptors under the EU legislation for pesticides and biocides. The criteria for biocides apply from 7 June 2018.
